Melanotan II
美拉诺坦II
Report date: 2026/03/04 20:01:44
NME
Base Information
Drug NameMelanotan II
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesThe University Of Arizona
China Registration ClassN/A
Develop Information
Active CompaniesHudson Biotech
Inactive CompaniesPalatin Technologies IncThe University Of Arizona
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksWikipedia